Centro Integral Oncológico Clara Campal (CIOCC)

Madrid 28050

0 studies enrolling now · 4 studies all time

What they study most

Gastric Cancer, HR+/HER2- Breast Cancer, Melanoma, Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Triple Negative Breast Cancer, Urothelial Carcinoma

Studies at this site

• Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype — Stopped early
• Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) — Running, not enrolling
• A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors — Completed
• Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer — Completed